LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

Search

Ovid therapeutics Inc

Suletud

SektorTervishoid

2.2 -3.51

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

2.16

Max

2.2800000000000002

Põhinäitajad

By Trading Economics

Sissetulek

-27M

-17M

Aktsiakasum

-0.125

Kasumimarginaal

-2,366.017

Töötajad

23

EBITDA

-5.5M

-18M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+133.77% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

12. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-42M

440M

Eelmine avamishind

5.71

Eelmine sulgemishind

2.2

Uudiste sentiment

By Acuity

50%

50%

161 / 344 Pingereas Healthcare

Ovid therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. juuni 2026, 23:56 UTC

News

Monster Beverage shares higher in after-market trading following Bernstein's initiation of coverage with a Market Perform rating. The stock has gained over four consecutive sessions.

11. juuni 2026, 23:52 UTC

Macro Event
News
Correlated Moves

The Australian Dollar has gained against the Singapore Dollar, supported by a slight decline in consumer inflation expectations and recent geopolitical developments.

11. juuni 2026, 23:51 UTC

News

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, reflecting concerns over inflation following a rise in the producer price index.

11. juuni 2026, 23:51 UTC

Correlated Moves
ETF Constituents
News
Social Media

SPDR S&P 500 ETF Trust rises in after-hours trading amid improved market sentiment and reduced geopolitical tensions in Iran, supported by strong performances from top holdings.

11. juuni 2026, 23:51 UTC

Correlated Moves
ETF Constituents
News
Social Media

Invesco QQQ Trust Series I rises after hours, supported by a Nasdaq 100 rally driven by technology stocks and easing inflation concerns.

11. juuni 2026, 23:51 UTC

News

The United States Oil Fund LP is higher in after-market trading amid reports of explosions in Iran raising concerns over oil supply stability.

11. juuni 2026, 23:41 UTC

Social Media
News
Event

Adobe Inc. shares fell in after-market trading despite record revenue of $6.62 billion, as investor concerns grew over CFO Dan Durn's upcoming departure.

11. juuni 2026, 23:41 UTC

ETF Constituents
Correlated Moves
Macro News
News

Vanguard Information Technology ETF rises after President Trump's decision to call off attacks against Iran, boosting investor confidence and contributing to gains in major indices.

11. juuni 2026, 23:41 UTC

Social Media
News

Western Digital Corp initiated exchange agreements with investors for over 1 million shares of SanDisk, contributing to the stock's higher after-market hours movement.

11. juuni 2026, 23:36 UTC

News
Correlated Moves

Ethereum is trading higher as market optimism rises amid U.S.-Iran tensions and the European Central Bank's interest rate hike. Earlier, it pulled back from a peak.

11. juuni 2026, 23:31 UTC

News

NVIDIA shares are higher in after-market trading following an upgrade to 'AA' by S&P Global and the announcement of its 2026 Annual Meeting.

11. juuni 2026, 23:26 UTC

ETF Constituents
Correlated Moves
News

Vanguard Growth ETF rises in after-market trading, buoyed by gains from Microsoft, NVIDIA, and Alphabet, despite remaining below its 20-day moving average.

11. juuni 2026, 23:16 UTC

ETF Constituents
Social Media
News
Correlated Moves

The iShares Russell 2000 ETF rose in after-market hours, supported by the Russell 2000 index's significant gain and contributions from PR and SATS.

11. juuni 2026, 23:11 UTC

News
Correlated Moves

CME Group plans to expand 24/7 gold trading, pending regulatory review. SPDR Gold Shares are rising in after-market hours amid geopolitical tensions.

11. juuni 2026, 23:11 UTC

News

USD/PLN trades lower as natural gas storage exceeds forecasts and initial jobless claims rise unexpectedly. Volatility persists during Thursday's session.

11. juuni 2026, 23:11 UTC

News
Correlated Moves

The USD/CZK is trading lower, reflecting a decline since Wednesday's close amid rising initial jobless claims and producer prices exceeding forecasts.

11. juuni 2026, 23:06 UTC

Correlated Moves
News

Vanguard Total Bond Market ETF trades higher in after-market hours as producer prices exceed expectations, prompting bargain hunting despite potential interest rate hike concerns.

11. juuni 2026, 23:06 UTC

News

Amgen engages Duke Clinical Research Institute to reassess Tavneos data amid FDA concerns, with shares trading higher in after-market hours.

11. juuni 2026, 23:03 UTC

Social Media
Correlated Moves
News

iShares Silver Trust trades higher after geopolitical tensions in Iran raise interest in safe-haven assets, supported by gold's recent gains.

11. juuni 2026, 23:03 UTC

ETF Constituents
News

The Vanguard Small-Cap ETF is higher in after-market trading, reflecting a broader upward trend in the Russell 2000 Index amid ongoing inflationary concerns.

11. juuni 2026, 23:02 UTC

News

The USD/THB is lower as U.S. economic data raises inflation concerns, impacting sentiment and Federal Reserve policy expectations during Thursday's trading session.

11. juuni 2026, 23:02 UTC

News

Gilead Sciences reported positive results from two Phase 3 trials for an HIV treatment. Shares are higher in after-market hours following a session pullback.

11. juuni 2026, 23:02 UTC

News

The USD/HUF is trading lower, reflecting a drop since Wednesday. Rising jobless claims and surging producer prices raise concerns about labor market strength and inflation.

11. juuni 2026, 23:02 UTC

Correlated Moves
News

The USD/SEK is declining, breaking a trend of higher daily closes, amid rising initial jobless claims that may impact Federal Reserve policy.

11. juuni 2026, 22:51 UTC

Correlated Moves
News

USD/SGD declines amid natural gas storage data surpassing forecasts. The pair has experienced unusual volatility, peaking briefly before steady declines into the afternoon.

11. juuni 2026, 22:51 UTC

Correlated Moves
News

The CHF/HKD is higher during Thursday's session, supported by the European Central Bank's recent interest rate hike amid inflation pressures.

11. juuni 2026, 20:07 UTC

News
Correlated Moves

The European Central Bank raised interest rates by 25 basis points, supporting modest gains in GBP/HKD amid inflation pressures from the Middle East conflict.

11. juuni 2026, 20:07 UTC

News
Correlated Moves

Natural gas storage data showed 108 billion cubic feet, surpassing forecasts. USD/NOK is trading higher, remaining above its 20-day moving average.

11. juuni 2026, 20:07 UTC

News
Correlated Moves

The USD/DKK is lower in Thursday's session, reflecting a decline in the US Dollar Index amid rising initial jobless claims data.

11. juuni 2026, 20:06 UTC

News
Correlated Moves

Intel Corp's stock is rising following a double upgrade from Bank of America, which raised its price target to $135 from $96.

Võrdlus sarnastega

Hinnamuutus

Ovid therapeutics Inc Prognoos

Hinnasiht

By TipRanks

133.77% tõus

12 kuu keskmine prognoos

Keskmine 5.33 USD  133.77%

Kõrge 7 USD

Madal 4 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Ovid therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

8 ratings

8

Osta

0

Hoia

0

Müü

Sentiment

By Acuity

161 / 344 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Ovid therapeutics Inc

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing soticlestat, a novel cholesterol 24 hydroxylase inhibitor, which is in Phase 3 clinical trials for the potential treatment of patients with resistant epilepsies; OV329, a GABA aminotransferase inhibitor which is in Phase 1 clinical trials for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It also develops OV815, that focuses on the mutations associated with KIF1A-associated neurological disorder (KAND); OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial; OV825, has advanced to potential candidate lead identification for the rare neurodevelopmental condition HNRNPH2 (Bain Syndrome); and OV882, a short hairpin RNA gene therapy for the treatment of Angelman syndrome. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
help-icon Live chat